pyridoxine has been researched along with chloroquine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Maroy, B | 1 |
Copeman, PW | 1 |
Cabanel, G; Chouteau, J; Marchal, A; Voog, R | 1 |
Stone, OJ; Willis, CJ | 1 |
Higuchi, S; Kimura, M; Nakaike, S; Ohzeki, M; Otomo, S; Sasajima, M; Tarumoto, Y | 1 |
BONTOUX, D; GODEAU, P; LEVY, R; SIGUIER, F | 1 |
HAMAGUCHI, T; ISHIBUCHI, M; KOTANI, Y | 1 |
HSU, JM; JONES, LG; MCKUSICK, AB; SHERWIN, RW | 1 |
Boratyński, J; Lipka, D | 1 |
Brandão, MAF; Ferreira, AO; Patrício, FB; Polonini, HC; Raposo, NRB; Silva, SL | 1 |
3 review(s) available for pyridoxine and chloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chloroquine.
Topics: Abnormalities, Drug-Induced; Animals; Ascorbic Acid; Child; Chloroquine; Enzymes; Eye Diseases; Female; Humans; Lysosomes; Pigmentation; Porphyrias; Pregnancy; Protein Biosynthesis; Psoriasis; Pyridoxine; Rabbits; Retina; Ultraviolet Rays | 1967 |
[Metalloproteinases. Structure and function].
Topics: 4-Aminobenzoic Acid; Animals; Apoptosis; Arthritis; Autoimmune Diseases; Cell Movement; Chloroquine; Drug Combinations; Enzyme Activation; Extracellular Matrix; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Membrane Proteins; Models, Molecular; Neoplasms; Neovascularization, Physiologic; Pantothenic Acid; Pyridoxine; Quinacrine; Tissue Inhibitor of Metalloproteinases | 2008 |
9 other study(ies) available for pyridoxine and chloroquine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Effect of Collagenan on joint disease associated with collagenous colitis].
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chloroquine; Colitis; Collagen; Drug Combinations; Female; Humans; Joint Diseases; Middle Aged; Pantothenic Acid; Pyridoxine; Quinacrine | 1986 |
[Asthma therapy with a combination of synthetic antimalarials (83 cases)].
Topics: Adolescent; Adult; Aged; Asthma; Chloroquine; Drug Synergism; Electrocardiography; Eosinophilia; Eye Manifestations; Glucocorticoids; Humans; Middle Aged; Pyridoxine; Quinacrine; Sympathomimetics; Vitamin B Complex | 1969 |
Chloroquine enhancement of inflammation.
Topics: Animals; Chloroquine; Dimethyl Sulfoxide; Inflammation; Phosphates; Pyridoxine; Rabbits; Skin | 1968 |
[Studies of D-penicillamine (5): effects on rat adjuvant arthritis (author's transl)].
Topics: Administration, Oral; Animals; Arthritis; Arthritis, Experimental; Chloroquine; Dexamethasone; Female; Gold Sodium Thiomalate; Penicillamine; Pyridoxine; Rats; Rats, Inbred Strains | 1981 |
[Therapeutic use of 22/360 (Collagenan) during various collagen diseases].
Topics: 4-Aminobenzoic Acid; Antimalarials; Chloroquine; Collagen Diseases; Drug Combinations; Humans; Pantothenic Acid; Pyridoxine; Quinacrine; Vitamin B Complex | 1963 |
[A CASE OF PORPHYRIA CONGENITA].
Topics: Child; Chloroquine; Corrinoids; Drug Therapy; Humans; Pathology; Porphyria, Erythropoietic; Porphyrias; Pyridoxine; Riboflavin; Vitamin B 12; Vitamin B Complex | 1964 |
URINARY EXCRETION OF PYRIDOXINE AND 4-PYRIDOXIC ACID IN RHEUMATOID ARTHRITIS.
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Therapy; Geriatrics; Humans; Metabolism; Pyridines; Pyridoxic Acid; Pyridoxine; Urine | 1964 |
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions.
Topics: Administration, Oral; Amlodipine; Chloroquine; Chromatography, High Pressure Liquid; Dapsone; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Isoxazoles; Phenytoin; Pyridoxine; Sulfadiazine; Sulfasalazine; Suspensions; Tetracycline; Trimethoprim; Zonisamide | 2016 |